Xendo B.V. is a Dutch consulting firm offering regulatory, clinical and quality services to life sciences companies.
Its services include regulatory sciences, clinical research, quality assurance, pharmacovigilance, medical information and digital transformation, serving pharmaceutical, biotechnology and medical device companies. Founded in 1990 and headquartered in the Netherlands, the company was acquired by ProPharma Group, Inc. in July 2018, with financial terms not disclosed. It reported revenue of USD 20.42 mn and EBITDA of USD 3.80 mn in 2016 and is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in